| # | Drug | Count |
|---|---|---|
| 0 | ALENDRONATE SODIUM | 56 |
| 1 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 16 |
| 2 | ETONOGESTREL AND ETHINYL ESTRADIOL | 10 |
| 3 | ALBUTEROL SULFATE | 9 |
| 4 | FINASTERIDE | 9 |
| 5 | RANITIDINE HYDROCHLORIDE | 8 |
| 6 | BOSENTAN | 7 |
| 7 | ERGOCALCIFEROL | 7 |
| 8 | IBANDRONATE SODIUM | 7 |
| 9 | LEVOTHYROXINE SODIUM | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANORECTAL OINTMENT | 1 | 0.0069 |
| 1 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 16 | 0.0061 |
| 2 | DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS | 1 | 0.0052 |
| 3 | MECASERMIN | 3 | 0.0044 |
| 4 | GALSULFASE | 6 | 0.0024 |
| 5 | TAURINE | 1 | 0.0021 |
| 6 | LARONIDASE | 4 | 0.0016 |
| 7 | SULFACETAMIDE SODIUM | 1 | 0.0014 |
| 8 | ELOSULFASE ALFA | 4 | 0.0014 |
| 9 | MIGLUSTAT | 1 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vitamin D [EPC] | 18 |
| 1 | Benzodiazepine [EPC] | 16 |
| 2 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 16 |
| 3 | Estrogen [EPC] | 15 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 15 |
| 5 | Corticosteroid [EPC] | 12 |
| 6 | Histamine-2 Receptor Antagonist [EPC] | 10 |
| 7 | Progestin [EPC] | 10 |
| 8 | 5-alpha Reductase Inhibitor [EPC] | 9 |
| 9 | Anti-epileptic Agent [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 16 | 0.0016 |
| 1 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0008 |
| 2 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0006 |
| 3 | Antihypoglycemic Agent [EPC] | 1 | 0.0005 |
| 4 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0003 |
| 5 | Recombinant Human Deoxyribonuclease 1 [EPC] | 3 | 0.0002 |
| 6 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0002 |
| 7 | Antifibrinolytic Agent [EPC] | 1 | 0.0002 |
| 8 | Cephalosporin Antibacterial [EPC] | 1 | 0.0002 |
| 9 | 5-alpha Reductase Inhibitor [EPC] | 9 | 0.0002 |